Form 4: HealthEquity Inc. Former Director Frank Corvino Executes Stock Option and Sells Shares

Former HealthEquity Inc. director Frank Corvino exercised stock options and sold shares on July 8, 2024.

Summary

• On July 8, 2024, Frank Corvino, a former director of HealthEquity, Inc. (HQY), executed a transaction involving the company's common stock.
• Corvino exercised stock options to acquire 6,482 shares at a price of $21.27 per share.
• Simultaneously, Corvino sold 1,223 shares at $81.8518 per share and 6,482 shares at a weighted average price of $81.8925 per share.
• Following these transactions, Corvino continues to beneficially own 6,070 shares of HealthEquity, Inc. common stock.
• The exercised option was immediately exercisable with an expiration date of February 1, 2026.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment. It provides factual information about stock option exercises and share sales.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by regulators and investors to ensure compliance with securities laws and to gain insights into management's perspective on the company's value.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly listed companies like HealthEquity, and is regulated by the SEC.
• Comparable companies such as Teladoc Health and Accolade also experience similar insider trading activities that are reported via Form 4 filings.
• The reported transactions are within the typical range observed for former directors exercising options and selling shares.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates